Rikard Karl Martin Nyman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rikard Karl Martin Nyman has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Arthur Theodore Johnson
School of BioSciences The University of Melbourne Melbourne VIC 3010 Australia
1 shared publication - Fernando Perez Rojo
UWA School of Agriculture and Environment/Institute of Agriculture, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia
1 shared publication - Maria Pazos-Navarro
School of Biological Sciences The University of Western Australia Perth WA Australia
1 shared publication - Megan Helen Ryan
University of Western Australia
1 shared publication - Parwinder Kaur
UWA School of Agriculture & Environment, University of Western Australia, Perth, Australia
1 shared publication - William Erskine
The University of Western Australia
1 shared publication
Latest Publications
- Open Access
- 1 January 2018
- Published by Taylor & Francis in Bioengineered
- Vol. 9 (1) , 214-221
CRISPR-Cas systems: ushering in the new genome editing era
In recent years there has been great progress with the implementation and utilization of Clustered Regularly Interspaced Palindromic Repeats (CRISPR) and CRISPR-associated protein (Cas) systems in the world of genetic engineering. Many forms of CRISPR-Cas9 have been developed as genome editing tools and techniques and, most recently, several non-genome editing CRISPR-Cas systems have emerged. Most of the CRISPR-Cas systems have been classified as either Class I or Class II and are further divided among several subtypes within each class. Research teams and companies are currently in dispute over patents for these CRISPR-Cas systems as numerous powerful applications are concurrently under development. This mini review summarizes the appearance of CRISPR-Cas systems with a focus on the predominant CRISPR-Cas9 system as well as the classifications and subtypes for CRISPR-Cas. Non-genome editing uses of CRISPR-Cas are also highlighted and a brief overview of the commercialization of CRISPR is provided.
- 1 January 2018
- Published by Taylor & Francis in Bioengineered
- Vol. 9 (1) , 214-221
Open AccessCRISPR-Cas systems: ushering in the new genome editing era
In recent years there has been great progress with the implementation and utilization of Clustered Regularly Interspaced Palindromic Repeats (CRISPR) and CRISPR-associated protein (Cas) systems in the world of genetic engineering. Many forms of CRISPR-Cas9 have been developed as genome editing tools and techniques and, most recently, several non-genome editing CRISPR-Cas systems have emerged. Most of the CRISPR-Cas systems have been classified as either Class I or Class II and are further divided among several subtypes within each class. Research teams and companies are currently in dispute over patents for these CRISPR-Cas systems as numerous powerful applications are concurrently under development. This mini review summarizes the appearance of CRISPR-Cas systems with a focus on the predominant CRISPR-Cas9 system as well as the classifications and subtypes for CRISPR-Cas. Non-genome editing uses of CRISPR-Cas are also highlighted and a brief overview of the commercialization of CRISPR is provided.